Home › NDC Lookup › RxCUI directory › RxCUI 1111106

Fidaxomicin 200 MG Oral Tablet — RxCUI 1111106

RxNorm drug concept · Semantic clinical drug
RxCUI 1111106 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1111106
Official nameFidaxomicin 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)4,446 prescriptions · 36 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fidaxomicin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Fidaxomicin is specifically designed to treat a gut infection called C. difficile-associated diarrhea — often called 'C. diff.' Unlike most antibiotics that spread throughout your...
  • What exactly is this antibiotic for? Is it like a regular antibiotic?
  • Good news — you can take fidaxomicin with or without food, whichever is easier for you. Food does reduce how quickly the drug is absorbed slightly, but studies showed that doesn't...
  • Can I take it with food, or does it have to be on an empty stomach?
📖 Read our full Fidaxomicin guide →

🕸️ Concept Web — How Fidaxomicin 200 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fidaxomicin 200 MG Oral Tablet RxCUI 1111106

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fidaxomicin 1111103
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dificid 1111107
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fidaxomicin Oral Tablet 1111105
    • Fidaxomicin Oral Product 1165014
    • Fidaxomicin Pill 1165015
    • Fidaxomicin Oral Tablet [Dificid] 1111109
    • Dificid Oral Product 1167543
    • Dificid Pill 1167544
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fidaxomicin 200 MG SCDC · 1111104
  • Fidaxomicin Oral Tablet SCDF · 1111105
  • Fidaxomicin Oral Product SCDG · 1165014
  • Fidaxomicin Pill SCDG · 1165015

Brand-Name Concepts

  • Fidaxomicin 200 MG Oral Tablet [Dificid] SBD · 1111110
  • Fidaxomicin 200 MG [Dificid] SBDC · 1111108
  • Fidaxomicin Oral Tablet [Dificid] SBDF · 1111109
  • Dificid Oral Product SBDG · 1167543
  • Dificid Pill SBDG · 1167544
  • Dificid BN · 1111107

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 1111106 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00480-2596-34 20 TABLET, FILM COATED in 1 BOTTLE (0480-2596-34) Fidaxomicin Teva Pharmaceuticals, Inc. 2025-07-15
13668-0745-21 20 TABLET, FILM COATED in 1 BOTTLE (13668-745-21) Fidaxomicin Torrent Pharmaceuticals Limited 2026-01-27
52015-0080-01 1 BOTTLE in 1 CARTON (52015-080-01) / 20 TABLET, FILM COATE... Dificid Merck Sharp & Dohme LLC 2011-05-27
52015-0700-22 1 POUCH in 1 CARTON (52015-700-22) / 1 BOTTLE, GLASS in 1 P... DIFICID Merck Sharp & Dohme LLC 2020-02-18
60505-4833-02 1 BOTTLE in 1 CARTON (60505-4833-2) / 20 TABLET, FILM COATE... Fidaxomicin Apotex Corp. 2026-02-03
Observed labelers: Merck Sharp & Dohme LLC (2) · Apotex Corp. (1) · Teva Pharmaceuticals, Inc. (1) · Torrent Pharmaceuticals Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.